LOS ANGELES (April 17, 2023) – equalpride, the nation’s leading LGBTQ+ owned and operated media company, announces the second season of their digital series celebrating LGBTQ+ stories. Spilling the Tea on Me features LGBTQ+ individuals sharing their journey towards authenticity and discussing their use of Allergan Aesthetics products including BOTOX® Cosmetic (onabotulinumtoxinA) and the JUVÉDERM® Collection of Fillers.
“Equalpride is thrilled to partner with Allergan Aesthetics to showcase the unique experiences and stories of LGBTQ+ individuals,” said Stuart Brockington, Executive Vice President of Brand Partnerships & Corporate Sales. “Spilling the Tea on Me spotlights those who have found confidence and self-expression and through it, are helping to further the conversation on individuals feeling confident in their skin.”
A recent survey shows that brands miss growth opportunities when their marketing plans lack an appropriate and authentic focus on BIPOC and LGBTQ+ communities. Partnerships that share authentic voices and celebrate these communities are increasingly important for brands of all sizes. equalpride is excited to continue their partnership with Allergan Aesthetics into a second year as the company continues to demonstrate its commitment to diversity and inclusion.
“Our corporate mission is to inspire confidence. We do this by embracing all communities while encouraging candid and authentic conversation,” said Chad Hacker, Vice President, Consumer and Digital Marketing, Allergan Aesthetics. “Celebrating individuality, through essential partnerships like this, help us continue to inspire more people to feel confident sharing their most authentic self.”
The second season of Spilling the Tea on Me premieres on Out, part of equalpride’s family of brands, and is now streaming. For more information, including videos and content from the first season, please visit Out.com/spilling-tea-me. Like and follow their social media channels at @outmagazine on Facebook, Instagram, Twitter, and TikTok.
BOTOX® COSMETIC IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:
· Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
· Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, and/or forehead lines
BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX® Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Serious and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have surgery; had surgery on your face; have trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to (it is not known if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, or Xeomin® in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of your eyelids and dry eyes.
APPROVED USES
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.
For more information refer to the Medication Guide or talk with your doctor.
To report a side effect, please call Allergan at 1-800-678-1605.
Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.
JUVÉDERM® VOLBELLA® XC and JUVÉDERM® Ultra XC Important Information
APPROVED USES
JUVÉDERM® VOLBELLA® XC injectable gel is for injection into the lips for lip augmentation and for correction of perioral lines in adults over the age of 21.
JUVÉDERM® Ultra XC is for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive JUVÉDERM® VOLBELLA® XC or JUVÉDERM® Ultra XC injectable gels?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or Gram-positive bacterial proteins used in these products.
What precautions should my doctor advise me about?
· Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during pregnancy or while breastfeeding has not been studied
· The safety of JUVÉDERM® VOLBELLA® XC in patients under 22 years, and the safety of JUVÉDERM® Ultra XC in patients under 18 years, has not been studied
· The safety and effectiveness of JUVÉDERM® VOLBELLA® XC in areas other than the lips and perioral area have not been established in controlled clinical studies
· The safety and effectiveness of JUVÉDERM® Ultra XC for areas other than the lips and perioral area for lip augmentation, or for facial wrinkles and folds, have not been established in controlled clinical studies
· Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formations) or pigmentation disorders, as use of these products may result in additional scars or changes in pigmentation
· Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment
· Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects
· Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of these products may result in an increased risk of infection
· Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site
· Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment
What are possible side effects?
The most common side effects included swelling, tenderness, bruising, firmness, lumps/bumps, redness, pain, discoloration, itching, and dryness. For JUVÉDERM® VOLBELLA® XC, side effects were predominantly mild or moderate, with a duration of 30 days or less. With JUVÉDERM® Ultra XC injectable gel, most side effects were mild or moderate and lasted 14 days or less.
One of the risks with using these products is unintentional injection into a blood vessel, and, while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
As with all skin injection procedures, there is a risk of infection.
To report a side effect with JUVÉDERM® VOLBELLA® XC or JUVÉDERM® Ultra XC, please call Allergan at 1-800-433-8871. Please also visit Juvederm.com for more information.
Available by prescription only.
About Allergan Aesthetics
Allergan Aesthetics, an AbbVie company, develops, manufactures, and markets a portfolio of leading aesthetics brands and products. Their aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Their goal is to consistently provide customers worldwide with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
About equalpride
Equalpride is the leading certified LGBTQ+ owned & operated media, digital, social, TV, print and entertainment company in the country. Our mission is to provide content of inspiration, hope, community, equality and love through our platforms that reach a vast majority of the American LGBTQ+ audience every month and increasingly women and people of color, which make up 50% and 25% of our monthly audience, respectively. We are a diverse community of storytellers, innovators, and influencers who believe in giving a voice to all people! Our portfolio includes some of the world’s most prestigious LGBTQ+ brands: Out, The Advocate, Out Traveler, Plus, PRIDE.COM, and the all-new Advocate Channel.
MEDIA CONTACT
Marie-Adélina de la Ferrière
Public Relations Specialist
marie-adelina@equalpride.com
(310) 943-5875